CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME AND POSTERIOR OCULAR INVOLVEMENT
Nathalie Morel(Délégation Paris 5), N. Costedoat‐Chalumeau(Délégation Paris 5), Véronique Le Guern(Délégation Paris 5), Mathilde Roumier(Hôpital Foch), Hanane Mehawej(Hôpital Cochin), Y. Benhamou(Inserm), Nicolas Maillard(Centre Hospitalier Universitaire de Saint-Étienne), Clémence Bonnet(University of California, Los Angeles), Bahram Bodaghi(Sorbonne Université), Jean‐Charles Piette(Sorbonne Université), Bertrand Godeau(Université Paris-Est Créteil), Julien Haroche(Inserm), Laurent Pérard(Hospices Civils de Lyon), Cécile Yelnik(Inserm), M. Lambert(Hôpital Claude Huriez), Antoine P. Brézin(Université Paris Cité)
Cited by 13
Related Papers
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520